Magle Chemoswed Holding AB Logo

Magle Chemoswed Holding AB

A CDMO serving the pharma and medical device industries from development to manufacturing.

MAGLE | ST

Overview

Corporate Details

ISIN(s):
SE0014401014 (+2 more)
LEI:
549300FNJZS6NGFB6M31
Country:
Sweden
Address:
Agneslundsvägen 27, 212 15 Malmö

Description

Magle Chemoswed Holding AB is a Contract Development and Manufacturing Organization (CDMO) serving the pharmaceutical and medical device industries. The company provides comprehensive services that support the entire product lifecycle, from initial development to commercial manufacturing. Core service areas include analytical development, process development, and solid-state chemistry. Its manufacturing operations are cGMP and ISO 13485 compliant, with specialized capabilities in lyophilization (freeze-drying), small-scale, semi-automated fill and finish services, and support for inhalation drug delivery systems. The company partners with clients to advance innovations from concept to finished product.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Magle Chemoswed Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Magle Chemoswed Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Magle Chemoswed Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-21 Stig Lökke Pedersen Other Other 384,000 11,520,000.00 SEK
2024-12-11 Martin Lidgard Other Buy 4,211 136,436.40 SEK
2024-12-05 Martin Lidgard Other Buy 632 21,740.80 SEK
2024-12-02 Martin Lidgard Other Buy 5,000 163,900.00 SEK

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.